Drug Invention Today
ISSN NO: 0975-7619
Drug Invention Today (DIT) was first published in 2009 by JPR Solutions. It is a journal, which publishes reviews, research papers and short communications . 
• Novel Drug Delivery Systems • Nanotechnology & Nanomedicine • Biotechnology related pharmaceutical technology • Polymeric bio-conjugates • Biological macromolecules • Biomaterials • Drug Information • Drug discovery/development • Screening of drugs from natural & synthetic origins • Novel therapeutic strategies • Combinatorial chemistry and parallel synthesis • Clinical trials • Case Reports
 Impact FactorTM ( India ) = 0.897 as on date (08.05.2017)
  Scopus Indexed ( link http://www.scimagojr.com/journalsearch.php?q=21100202909&tip=sid&clean=0)
Journal Metrics for this   Drug Invention Today (Source ID: 21100202909): 2014 (SNIP) Source Normalized Impact Per Paper : 0.402; SCImago Journal Rank (SJR):0.301; Impact Per Publication : 0.517 (Top level : Life Science)
Indexed in
NCBI NLM Catalogue,
SCOPUS, EMBASE (Elsevier),
ROAD, CABI, Google Scholar,
Open J-Gate, Biblioteca,
Science Central,
Index Scholar, Indian Citation Index,
 AYUSH Research Portal, 
Indexed Copernicus, EBSCO, PSOAR,
Ulrichs Directory of Periodicals, etc.

Manuscripts Published

Journal: Drug Invention Today , Volume: 4, Issue: May
Article Id: JPRS-MSNS-00001090
Title: Antibacterial and antifungal screening of ethanol leaf extract of Wrightia tinctoria against some pathogenic microorganisms
Category: Microbiological Study (on Natural/ Synthetic drug)
Section: Research Article
Country: India
View Article

The present investigation focuses on the antimicrobial screening of leaf extract of Wrightia tinctoria against the selected bacterial and fungal strains. Leaf extract of Wrightia tinctoria was more potent in inhibiting the growth of Klebsiella pneumoniae and Escherichia coli with different degree of inhibition. Wrightia tinctoria completely inhibited Trichophyton floccosum at 500- 1000ppm. The results support that the plant extract containing compound that can form the basis for the development of novel broad spectrum antimicrobial formulations against Klebsiella pneumoniae, Escherichia coli and Trichophyton floccosum.